Home > > Global Anesthesia CO2 Absorbent Market Report
The Anesthesia CO2 Absorbent market was valued at $124.6 Million in 2024, and is projected to reach $205.4 Million by 2031 growing at a CAGR of 7.46% from 2025 to 2031. Medisorb segment is expected to be the highest contributor to this market, with $44.6 Million in 2024, and is anticipated to reach $69.1 Million by 2031, registering a CAGR of 6.49%. Dragersorb segment is anticipated to reach $31.2 Million by 2031 with the highest CAGR of 10.45%. Medisorb and Soda Lime segments collectively expected to account for about 57.0% share of the Anesthesia CO2 Absorbent market in 2024, with the former constituting around 35.8% share. Dragersorb and Amsorb segments are expected to witness significant growth rates at a CAGR of 10.45% and 9.61% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 24.2% in the overall Anesthesia CO2 Absorbent market in 2024, and is anticipated to reach 28.6% by 2031.